Skip to main content

Advertisement

SpringerLink
Log in

Clinical Guidelines and Definitions of Autoinflammatory Diseases: Contrasts and Comparisons with Autoimmunity—a Comprehensive Review

  • Published:
Clinical Reviews in Allergy & Immunology Aims and scope Submit manuscript

Abstract

Autoinflammatory diseases (AIDs) and autoimmune diseases (ADs) are characterized by an aberrant chronic activation of the immune system which causes tissue inflammation and damage in genetically predisposed individuals. Pathogenetic mechanisms underlying this damage differ between these two types of diseases; in AIDs, the innate immune system is directly responsible for tissue inflammation, while in ADs it works by activating the adaptive immune system, which becomes the main effector of the inflammatory process. Despite the fact that AIDs have only been recently defined, they are older than ADs. The innate immune system is found in plants and animals, and it developed earlier than the adaptive immune system, which first appeared in jawed vertebrates. According to genetic background and clinical, serological, and radiological findings, AIDs and ADs might be considered as a single spectrum of disorders, with a wide range of manifestations. Indeed, autoinflammatory-like diseases have been reported in simple organisms such as Drosophila melanogaster and Caenorhabditis elegans. We analyzed here the main pathogenetic and clinical features of these two groups of diseases mostly dealing with their similarities and differences.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Sanabria N, Goring D, Nürnberger T, Dubery I (2008) Self/nonself perception and recognition mechanisms in plants: a comparison of self-incompatibility and innate immunity. New Phytol 178:503–514

    Article  PubMed  CAS  Google Scholar 

  2. Ohta Y, Okamura K, McKinney C, Bartl S, Hashimoto K, Flajnik MF (2000) Primitive synteny of vertebrate HC class I and class II genes. Proc Natl Acad Sci USA 97:4712–4717

    Article  PubMed  CAS  Google Scholar 

  3. Kim KD, Zhao J, Auh S, Yang X, Du P, Tang H, Fu YX (2007) Adaptive immune cells temper initial innate responses. Nat Med 10:1248–1252

    Google Scholar 

  4. Toitou I (2012) New genetic interpretation of old diseases. Autoimmun Rev 12(1):5–9

    Article  Google Scholar 

  5. Doria A, Zen M, Bettio S, Gatto M, Bassi N, Nalotto L et al (2012) Autoinflammation and autoimmunity: bridging the divide. Autoimmun Rev 12(1):22–30

    Article  PubMed  CAS  Google Scholar 

  6. Masters SL, Somin A, Aksentijevich I, Kastner DL (2009) Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory diseases. Annu Rev Immunol 27:621–668

    Article  PubMed  CAS  Google Scholar 

  7. Shinar Y, Obici L, Aksentijevich I, Bennetts B, Austrup F, Ceccherini I et al (2012) Guidelines for the genetic diagnosis of hereditary recurrent fevers. Ann Rheum Dis 71(10):1599–605

    Article  PubMed  CAS  Google Scholar 

  8. Cho JH, Gregersen PK (2011) Genomics and the multifactorial nature of human autoimmune disease. N Engl J Med 365:1612–1623

    Article  PubMed  CAS  Google Scholar 

  9. Pontillo A, Girardelli M, Kamada AJ, Pancotto JA, Donadi EA, Crovella S et al (2012) Polymorphisms in inflammasome genes are involved in the predisposition to systemic lupus erythematosus. Autoimmunity 45:271–278

    Article  PubMed  CAS  Google Scholar 

  10. Punzi L, Scanu A, Ramonda R, Oliviero F (2012) Gout as autoinflammatory disease: new mechanisms for more appropriated treatment targets. Autoimmun Rev 12(1):66–71

    Article  PubMed  CAS  Google Scholar 

  11. Torgerson TR, Ochs HD (2007) Immune dysregulation, polyendocrinopathy, enteropathy, X-linked: forkhead box protein 3 mutations and lack of regulatory T cells. J Allergy Clin Immunol 120:744–750

    Article  PubMed  CAS  Google Scholar 

  12. Worth A, Thrasher AJ, Gaspar HB (2006) Autoimmune lymphoproliferative syndrome: molecular basis of disease and clinical phenotype. Br J Haematol 133:124–140

    Article  PubMed  CAS  Google Scholar 

  13. Pétrilli V, Dostert C, Muruve DA, Tschopp J (2007) The inflammasome: a danger sensing complex triggering innate immunity. Curr Opin Immunol 19:615–622

    Article  PubMed  Google Scholar 

  14. Sfriso P, Ghirardello A, Botsios C, Tonon M, Zen M, Bassi N et al (2010) Infections and autoimmunity: the multifaceted relationship. J Leukoc Biol 87:385–395

    Article  PubMed  CAS  Google Scholar 

  15. Doria A, Zampieri S, Sarzi-Puttini P (2008) Exploring the complex relationships between infections and autoimmunity. Autoimmun Rev 8:89–91

    Article  PubMed  Google Scholar 

  16. Shoenfeld Y, Agmon-Levin N (2011) ‘ASIA’ - autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun 36:4–8

    Article  PubMed  CAS  Google Scholar 

  17. Bassi N, Luisetto R, Del Prete D, Ghirardello A, Ceol M, Rizzo S et al (2012) Induction of the ‘ASIA’ syndrome in NZB/NZWF1 mice after injection of complete Freund’s adjuvant (CFA). Lupus 21:203–209

    Article  PubMed  CAS  Google Scholar 

  18. Kastner DL, Aksentijevich KI, Goldbach-Mansky R (2010) Autoinflammatory disease reloaded: a clinical perspective. Cell 140:784–790

    Article  PubMed  CAS  Google Scholar 

  19. Aringer M, Smolen JS (2012) Therapeutic blockade of TNF in patients with SLE—promising or crazy? Autoimmun Rev 11(5):321–325

    Article  PubMed  CAS  Google Scholar 

  20. Doria A, Sherer Y, Meroni PL, Shoenfeld Y (2005) Inflammation and accelerated atherosclerosis: basic mechanisms. Rheum Dis Clin North Am 31:355–362

    Article  PubMed  Google Scholar 

  21. Stojanovich L (2010) Stress and autoimmunity. Autoimmun Rev 9:271–276

    Article  Google Scholar 

  22. Martinon F, Mayor A, Tschopp J (2009) The inflammasomes: guardians of the body. Annu Rev Immunol 27:229–265

    Article  PubMed  CAS  Google Scholar 

  23. Konè-Paut I, Piram M (2012) Targeting interleukin-1β in CAPS [cryopyrin-associated periodic] syndromes: what did we learn? Autoimmun Rev 12(1):77–80

    Article  PubMed  Google Scholar 

  24. Lamkanfi M, Walle LV, Kanneganti TD (2011) Deregulated inflammasome signaling in disease. Immunol Rev 243:163–173

    Article  PubMed  Google Scholar 

  25. Rekvig OP, Putterman C, Casu C, Gao HX, Ghirardello A, Mortensen ES et al (2012) Autoantibodies in lupus: culprits or passive bystanders? Autoimmun Rev 11:596–603

    Article  PubMed  Google Scholar 

  26. Bassi N, Ghirardello A, Blank M, Zampieri S, Sarzi-Puttini P, Mantovani A et al (2010) IgG anti-pentraxin 3 antibodies in systemic lupus erythematosus. Ann Rheum Dis 69:1704–1710

    Article  PubMed  CAS  Google Scholar 

  27. Sfriso P, Caso F, Tognon S, Galozzi P, Gava A, Punzi L (2012) Blau syndrome, clinical and genetic aspects. Autoimmun Rev 12(1):44–51

    Article  PubMed  CAS  Google Scholar 

  28. Muscari I, Iacoponi F, Cantarini L, Lucherini OM, Simonini G, Brizi MG et al (2012) The diagnostic evaluation of patients with potential adult-onset autoinflammatory disorders: our experience and review of the literature. Autoimmun Rev 12(1):10–13

    Article  PubMed  Google Scholar 

  29. Soriano A, Manna R (2012) Familial Mediterranean fever: new phenotypes. Autoimmun Rev 12(1):31–37

    Article  PubMed  Google Scholar 

  30. Bano S, Bombardieri S, Doria A, Iaccarino L, Lehmann P, Mosca M (2006) Lupus erythematosus and the skin. Clin Exp Rheumatol 24:S26–S35

    PubMed  CAS  Google Scholar 

  31. Drenth JP, Boom BW, Toonstra J, Van der Meer JW (1994) Cutaneous manifestations and histologic findings in hyperimmunoglobulin D syndrome. International Hyper IgD Study Group. Arch Dermatol 130:59–65

    Article  PubMed  CAS  Google Scholar 

  32. Lamprecht P, Moosig F, Adam-Klages S, Mrowietz U, Csernok E, Kirrstetter M et al (2004) Small vessel vasculitis and relapsing panniculitis in tumor necrosis factor receptor associated periodic syndrome (TRAPS). Ann Rheum Dis 63:1518–1520

    Article  PubMed  CAS  Google Scholar 

  33. Riera E, Olivé A, Narváez J, Holgado S, Santo P, Mateo L et al (2011) Adult onset Still’s disease: review of 41 cases. Clin Exp Rheumatol 29:331–336

    PubMed  CAS  Google Scholar 

  34. Cantarini L, Lucherini OM, Muscari I, Frediani B, Galeazzi M, Brizi MG et al (2012) Tumour necrosis factor receptor-associated periodic syndrome (TRAPS): state of the art and future perspectives. Autoimmun Rev 12(1):38–43

    Article  PubMed  CAS  Google Scholar 

  35. Briani C, Doria A, Sarzi-Puttini P, Dalakas MC (2006) Update on idiopathic inflammatory myopathies. Autoimmunity 39:161–170

    Article  PubMed  CAS  Google Scholar 

  36. Di Pietra L, Gardiman M, Terranova C (2012) Postpartum maternal death associated with undiagnosed Hodgkin’s lymphoma. Med Sci Law 52:174–177

    Article  PubMed  Google Scholar 

  37. Uttenthal BJ, Layton DM, Vyse TJ, Schreiber BE (2012) Clinical problem-solving. The wolf at the door. N Engl J Med 366:2216–2221

    Article  PubMed  CAS  Google Scholar 

  38. Ebert EC, Hagspiel KD (2011) Gastrointestinal and hepatic manifestations of systemic lupus erythematosus. J Clin Gastroenterol 45:436–441

    Article  PubMed  CAS  Google Scholar 

  39. Maestroni S, Di Corato PR, Cumetti D, Salvatore S, Ghidoni S, Prisacaru L et al (2012) Recurrent pericarditis: autoimmune or autoinflammatory? Autoimmun Rev 12(1):60–65

    Article  PubMed  CAS  Google Scholar 

  40. Merlini G, Obici L (2012) Amyloidosis in autoinflammatory syndromes. Autoimmun Rev 12(1):14–17

    Article  PubMed  Google Scholar 

  41. Nakamura T (2011) Amyloid A, amyloidosis secondary to rheumatoid arthritis: pathophysiology and treatments. Clin Exp Rheumatol 29:850–857

    PubMed  Google Scholar 

  42. Doria A, Cutolo M, Ghirardello A, Zen M, Villalta D, Tincani A et al (2012) Effect of pregnancy on serum cytokines in SLE patients. Arthritis Res Ther 14:R66

    Article  PubMed  CAS  Google Scholar 

  43. Higgs BW, Zhu W, Richman L, Fiorentino DF, Greenberg SA, Jallal B et al (2012) Identification of activated cytokine pathways in the blood of systemic lupus erythematosus, myositis, rheumatoid arthritis, and scleroderma patients. Int J Rheum Dis 15:25–35

    Article  PubMed  CAS  Google Scholar 

  44. Shoenfeld Y, Szyper-Kravitz M, Witte T, Doria A, Tsutsumi A, Tatsuya A et al (2007) Autoantibodies against protective molecules—C1q, C-reactive protein, serum amyloid P, mannose-binding lectin, and apolipoprotein A1: prevalence in systemic lupus erythematosus. Ann N Y Acad Sci 1108:227–239

    Article  PubMed  CAS  Google Scholar 

  45. Martini A (2012) Systemic juvenile idiopathic arthritis. Autoimmun Rev 12(1):56–59

    Article  PubMed  CAS  Google Scholar 

  46. Zandman-Goddard G, Orbach H, Agmon-Levin N, Boaz M, Amital H, Szekanecz Z, et al. Hyperferritinemia is associated with serologic antiphospholipid syndrome in SLE patients. Clin Rev Allergy Immunol 2011; doi: 10.1007/s12016-011-8264-0

  47. Zen M, Bassi N, Nalotto L, Canova M, Bettio S, Gatto M et al (2012) Disease activity patterns in a monocentric cohort of SLE patients: a seven-year follow-up study. Clin Exp Rheumatol 30(6):856–863

    PubMed  Google Scholar 

  48. Bartoloni E, Alunno A, Bistoni O, Bizzaro N, Migliorini P, Morozzi G et al (2012) Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and antiviral citrullinated peptide 2 antibodies in rheumatoid arthritis: an Italian multicentric study and review of the literature. Autoimmun Rev 11(11):815–820

    Article  PubMed  CAS  Google Scholar 

  49. Iaccarino L, Ghirardello A, Canova M, Zen M, Bettio S, Nalotto L et al (2011) Anti-annexins autoantibodies: their role as biomarkers of autoimmune diseases. Autoimmun Rev 10:553–558

    Article  PubMed  CAS  Google Scholar 

  50. Ghirardello A, Villalta D, Morozzi G, Afeltra A, Galeazzi M, Gerli R et al (2011) Diagnostic accuracy of currently available anti-double-stranded DNA antibody assays. An Italian multicentre study. Clin Exp Rheumatol 29:50–56

    PubMed  Google Scholar 

  51. Ghirardello A, Doria A, Zampieri S, Tarricone E, Tozzoli R, Villalta D et al (2004) Antinucleosome antibodies in SLE: a two-year follow-up study of 101 patients. J Autoimmunity 22:235–240

    Article  CAS  Google Scholar 

  52. Ghirardello A, Bendo R, Rampudda ME, Bassi N, Zampieri S, Doria A (2009) Commercial blot assays in the diagnosis of systemic rheumatic diseases. Autoimmun Rev 8:645–649

    Article  PubMed  CAS  Google Scholar 

  53. Briani C, Lucchetta M, Ghirardello A, Toffanin E, Zampieri S, Ruggero S et al (2009) Neurolupus is associated with anti-ribosomal P protein antibodies: an inception cohort study. J Autoimmun 32:79–84

    Article  PubMed  CAS  Google Scholar 

  54. Zampieri S, Mahler M, Blüthner M, Qiu Z, Malmegrim K, Ghirardello A et al (2003) Recombinant anti-P proteins autoantibodies isolated from a human autoimmune library: reactivity, specificity and epitope recognition. Cell Mol Life Sci 60:588–598

    Article  PubMed  CAS  Google Scholar 

  55. Govoni M, Bombardieri S, Bortoluzzi A, Caniatti L, Casu C, Conti F et al (2012) Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patients. Rheumatology 51:157–168

    Article  PubMed  Google Scholar 

  56. Ghirardello A, Doria A, Vesco P, Vaccaro E, Bernardi C, Catani C et al (1996) Blotting pattern of IgG Anti-(U1)RNP antibodies in mixed connective tissue disease. Rheumatol Int 16:145–150

    Article  PubMed  CAS  Google Scholar 

  57. Ghirardello A, Rampudda M, Ekholm L, Bassi N, Tarricone E, Zampieri S et al (2010) Diagnostic performance and validation of autoantibody testing in myositis by a commercial line blot assay. Rheumatology (Oxford) 49:2370–2374

    Article  CAS  Google Scholar 

  58. Ghirardello A, Zampieri S, Tarricone E, Iaccarino L, Gorza L, Doria A (2011) Cutting edge issues in polymyositis. Clin Rev Allergy Immunol 41:179–189

    Article  PubMed  CAS  Google Scholar 

  59. Zen M, Canova M, Campana C, Bettio S, Nalotto L, Rampudda M et al (2011) The kaleidoscope of glucorticoid effects on immune system. Autoimmun Rev 10:305–310

    Article  PubMed  CAS  Google Scholar 

  60. Vigo G, Zulian F (2012) Periodic fevers with aphthous stomatitis, pharyngitis, and adenitis (PFAPA). Autoimmun Rev 12(1):52–55

    Article  PubMed  Google Scholar 

  61. Doria A, Zen M, Canova M, Bettio S, Bassi N, Nalotto L et al (2010) SLE diagnosis and treatment: when early is early. Autoimmun Rev 10:55–60

    Article  PubMed  CAS  Google Scholar 

  62. Gattorno M, Federici S, Pelagatti MA, Caorsi R, Brisca G, Malattia C et al (2008) Diagnosis and management of autoinflammatory diseases in childhood. J Clin Immunol 28:S73–S83

    Article  PubMed  Google Scholar 

  63. Bhat A, Naguwa SM, Cheema GS, Gershwin ME (2009) Colchicine revisited. Ann N Y Acad Sci 1173:766–773

    Article  PubMed  CAS  Google Scholar 

  64. Shugaiv E, Tüzün E, Mutlu M, Kiyat-Atamer A, Kurtuncu M, Akman-Demir G (2011) Mycophenolate mofetil as a novel immunosuppressant in the treatment of neuro-Behçet’s disease with parenchymal involvement: presentation of four cases. Clin Exp Rheumatol 29:S64–S67

    PubMed  Google Scholar 

  65. Iaccarino L, Rampudda M, Canova M, Della Libera S, Sarzi-Puttinic P, Doria A (2007) Mycophenolate mofetil: what is its place in the treatment of autoimmune rheumatic diseases? Autoimmun Rev 6:190–195

    Article  PubMed  CAS  Google Scholar 

  66. Rosenblum H, Amital H (2011) Anti-TNF therapy: safety aspects of taking the risk. Autoimmun Rev 10:563–568

    Article  PubMed  Google Scholar 

  67. Buch MH, Rubbert-Roth A, Ferraccioli G (2012) To switch or not to switch after a poor response to a TNFα blocker? It is not only a matter of ACR20 OR ACR50. Autoimmun Rev 11:558–562

    Article  PubMed  Google Scholar 

  68. Caorsi R, Federici S, Gattorno M (2012) Biologic drugs in inflammatory syndromes. Autoimmun Rev 12(1):81–86

    Article  PubMed  CAS  Google Scholar 

  69. Atzeni F, Sarzi-Puttini P, Gorla R, Marchesoni A, Caporali R (2011) Switching rheumatoid arthritis treatments: an update. Autoimmun Rev 10:397–403

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Rheumatology, Department of Medicine, University of Padua, Via Giustiniani, 2, 35128, Padua, Italy

    M. Zen, M. Gatto, M. Domeneghetti, L. Palma, E. Borella, L. Iaccarino, L. Punzi & A. Doria

Authors
  1. M. Zen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Gatto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Domeneghetti
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. L. Palma
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E. Borella
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. L. Iaccarino
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. L. Punzi
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. A. Doria
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Doria.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zen, M., Gatto, M., Domeneghetti, M. et al. Clinical Guidelines and Definitions of Autoinflammatory Diseases: Contrasts and Comparisons with Autoimmunity—a Comprehensive Review. Clinic Rev Allerg Immunol 45, 227–235 (2013). https://doi.org/10.1007/s12016-013-8355-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12016-013-8355-1

Keywords

Search

Navigation